In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: Antimicrobial susceptibility patterns in different groups of species

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 820-823

  Rodríguez Avial, Iciar ^a   Rodríguez Avial, Carmen ^a   Culebras, Esther ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; TELITHROMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CELL HETEROGENEITY; DRUG ACTIVITY; GENOTYPE; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS BOVIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CATTLE; DRUG RESISTANCE, BACTERIAL; HUMANS; KETOLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; SPECIES SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS BOVIS; VIRIDANS STREPTOCOCCI;

EID: 12944293056     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.820-823.2005     Document Type: Article

References (23)

1. Alcaide, F., M. A. Benítez, J. Carratalá, F. Gudiol, J. Liñares, and R. Martín. 2001. In vitro activities of the new ketolide HMR3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer. Antimicrob. Agents Chemother. 45:624-626.
2. Aracil, B., M. Min̄ambres, J. Oteo, C. Torres, J. L. Gómez-Garcés, and J. I. Alós. 2001. High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J. Antimicrob. Chemother. 48:587-595.
3. Arpin, C., M.-H. Canron, J. Maugein, and C. Quentin. 1999. Incidence of mefA and mefE genes in viridans group streptococci. Antimicrob. Agents Chemother. 43:2335-2336.
4. Coykendall, A. L. 1989. Classification and identification of the viridans streptococci. Clin. Microbiol. Rev. 2:315-328.
5. de Azavedo, J. C. S., L. Trpeski, S. Pong-Porter, S. Matsumura, the Canadian Bacterial Surveillance Network, and D. E. Low. 1999. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrob. Agents Chemother. 43:2299-2301.
6. Diekema, D. J., M. L. Beach, M. A. Pfaller, R. N. Jones, and the SENTRY Participants Group. 2001. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin. Microb. Infect. 7:152-157.
7. Doern, G. V., M. J. Ferraro, A. B. Brueggemann, and K. L. Ruoff. 1996. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:891-894.
8. Gershon, A. S., J. C. S. de Azavedo, A. McGeer, K. J. Ostrowska, D. Church, D. J. Hoban, G. K. M. Harding, K. Weiss, L. Abbott, F. Smaill, M. Gourdeau, G. Murray, and D. E. Low. 2002. Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada. Antimicrob. Agents Chemother. 46:1553-1556.
9. Jacobs, J. A., G. J. van Baar, N. H. H. J. London, J. H. T. Tjhie, L. M. Schouls, and E. E. Stobberingh. 2001. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group. Antimicrob. Agents Chemother, 45:2375-2377.
10. Lyytikäinen, O., M. Rautio, P. Carlson, V.-J. Anttila, R. Vuento, H. Sarkkinen, A. Kostiala, M. L. Vaisanen, A. Kanervo, and P. Ruutu. 2004. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance. J. Antimicrob. Chemother. 53:631-634.
11. Malhotra-Kumar, S., C. Lammens, A. Martel, C. Mallentjer, S. Chapelle, J. Verhoeven, M. Wijdooghe, F. Haesebrouck, and H. Goossens. 2004. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium. J. Antimicrob. Chemother. 53:271-276.
12. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing; 14th informational supplement, M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Perez-Trallero, E., D. Vicente, M. Montes, J. M. Marimon, and L. Pin̄eiro. 2001. High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J. Antimicrob. Chemother. 48:225-229.
14. Rennenberg, J., L. L. Niemann, and E. Gustschik. 1997. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J. Antimicrob. Chemother. 39:135-140.
15. Rodríguez-Avial, I., C. Rodríguez-Avial, E. Culebras, and J. J. Picazo. 2003. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int. J. Antimicrob. Agents 21:536-541.
16. Ruoff, K., R. A. Whiley, and D. Beighton. 2003. Streptococcus, p. 405-421. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
17. Seppälä, H., M. Haanperä, M. Al-Juhaish, H. Järvinen, J. Jalava, and P. Houvinen. 2003. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J. Antimicrob. Chemother. 52:636-644.
18. Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTK) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
19. Sutclifie, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
20. Teng, L. J., P. R. Hsueh, Y. C. Cheng, S. W. Ho, and K. T. Luh. 1998. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J. Antimicrob. Chemother. 41:621-627.
21. Teng, L. J., P. R. Hsueh, S. W. Ho, and K. T. Luh. 2001. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob. Agents Chemother. 45:3362-3365.
22. Uh, Y., D. H. Shin, I. H. Jang, G. Y. Hwang, M. K. Lee, K. J. Yoon, and H. Y. Kim. 2004. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans streptococci from blood cultures in Korea. J. Antimicrob. Chemother. 53:1095-1097.
23. Walsh, F., J. Willcock, and S. Amyes. 2003. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J. Antimicrob. Chemother. 52:345-353.